19:34 , Dec 2, 2016 |  BC Week In Review  |  Financial News

MetaboGen completes venture financing

MetaboGen raised SEK4 million ($431,600) in the third and final investment from BioGaia, bringing the total raised by MetaboGen from the investor to SEK12 million ($1.4 million). MetaboGen AB , Gothenburg, Sweden ...
08:00 , Dec 7, 2009 |  BC Week In Review  |  Company News

Pergamum board of directors update

Pergamum AB , Stockholm, Sweden   Business: Dermatology   Appointed: Jorgen Thorball, founder of BioGaia HealthCare Sweden, as chairman; he replaces Bjoern Olander, who will remain a director  ...
07:00 , Jun 10, 2002 |  BC Week In Review  |  Company News

BioGaia AB, Novozymes deal

BIOG sold its European cGMP-certified manufacturing unit BioGaia Fermentation (Lund, Sweden) to enzyme specialist Novozymes. BIOG said the sale would afford it a SEK66 million ($6.7 million) post-tax capital gain and about SEK110 million ($11...
07:00 , Jun 10, 2002 |  BioCentury  |  Finance

Ebb & Flow

The biotech industry raised a record amount of money in the first quarter, $5.7 billion, the best start to any year for the industry with the exception of 2000, when biotech took in $13.1 billion...
07:00 , Jun 3, 2002 |  BC Extra  |  Company News

Novozymes buys BioGaia unit

BioGaia (SSE:BIOG) sold its European cGMP-certified manufacturing unit BioGaia Fermentation (Lund, Sweden) to enzyme specialist Novozymes (Bagsvaerd, Denmark). BIOG said the sale would afford it a SEK66 million ($6.7 million) post-tax capital gain and about...
07:00 , Jul 9, 2001 |  BC Week In Review  |  Company News

BioGaia AB, Amersham Pharmacia Biotech Ltd. deal

The companies expanded their protein production deal under which BIOG was responsible for fermenting Amersham's proteins for use in industrial separation products. As expanded, BIOG also will be responsible for reprocessing the proteins into purified...
08:00 , Nov 13, 2000 |  BioCentury  |  Finance

Schroder's plans for IBT

Rothschild Asset Management no longer holds the strings to International Biotech Trust (LSE:IBT). Last week, the biotech investment company appointed Schroder Ventures, the private equity group, as investment advisers and overseers to the trust's administration....
08:00 , Mar 15, 1999 |  BioCentury  |  Finance

Week 1: So far so good

MorphoSys (NMarkt:MORG) didn't disappoint buyers of its $28 million IPO on the Neuer Markt, gaining 43 percent in trading after last Tuesday's offering to close Friday at Eur35.7, a market cap of Eur122.4 million ($132.6...
08:00 , Jan 25, 1999 |  BioCentury  |  Finance

Genentech pushes past a magic number

While Genentech posted solid 1998 earnings last week, investors will have only one more look at a GNE P&L statement prior to Roche 's June 30 deadline to exercise its option to buy the 34.7...
07:00 , Jul 27, 1998 |  BC Week In Review  |  Company News

MultiFerm AB supply/service news

MultiFerm changed its name to BioGaia Fermentation AB. The company, a contract manufacturer, became a subsidiary of BioGaia Biologics AB last year. MultiFerm AB, Lund, Sweden   Business: Supply/Service  ...